Vaccination with LAG-3Ig (IMP321) and peptides induces specific CD4 and CD8 T-cell responses in metastatic melanoma patients - report of a phase I/IIa clinical trial.
Legat A., Maby-El Hajjami H., Baumgaertner P., Cagnon L., Abed Maillard S., Geldhof C., Iancu E.M., Lebon L., Guillaume P., Dojcinovic D. et al., 2016. Clinical Cancer Research, 22 (6) pp. 1330-1340. Peer-reviewed.
ici le détail